F.L. Putnam Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Buy |
209,651
+6,050
| +3% | +$353K | 0.19% | 105 |
|
|
2025
Q4 | $11M | Buy |
203,601
+17,300
| +9% | +$832K | 0.16% | 111 |
|
|
2025
Q3 | $8.4M | Buy |
186,301
+64,133
| +52% | +$3M | 0.13% | 129 |
|
|
2025
Q2 | $5.66M | Sell |
122,168
-99,911
| -45% | -$4.9M | 0.1% | 156 |
|
|
2025
Q1 | $13.5M | Buy |
222,079
+76,321
| +52% | +$4.45M | 0.25% | 83 |
|
|
2024
Q4 | $8.24M | Buy |
145,758
+1,580
| +1% | +$88.3K | 0.15% | 128 |
|
|
2024
Q3 | $7.52M | Sell |
144,178
-5,561
| -4% | -$261K | 0.14% | 135 |
|
|
2024
Q2 | $6.22M | Buy |
149,739
+40,483
| +37% | +$1.81M | 0.12% | 142 |
|
|
2024
Q1 | $5.92M | Buy |
109,256
+12,750
| +13% | +$650K | 0.13% | 135 |
|
|
2023
Q4 | $4.95M | Buy |
96,506
+11,352
| +13% | +$596K | 0.12% | 139 |
|
|
2023
Q3 | $4.94M | Sell |
85,154
-32,209
| -27% | -$1.97M | 0.14% | 134 |
|
|
2023
Q2 | $7.51M | Sell |
117,363
-31,701
| -21% | -$2.13M | 0.2% | 101 |
|
|
2023
Q1 | $10.3M | Sell |
149,064
-8,562
| -5% | -$604K | 0.34% | 71 |
|
|
2022
Q4 | $11.3M | Buy |
157,626
+49,393
| +46% | +$3.72M | 0.41% | 60 |
|
|
2022
Q3 | $7.69M | Buy |
108,233
+48,956
| +83% | +$3.55M | 0.3% | 82 |
|
|
2022
Q2 | $4.56M | Buy |
59,277
+535
| +0.9% | +$40.7K | 0.17% | 121 |
|
|
2022
Q1 | $4.29M | Buy |
58,742
+6,013
| +11% | +$404K | 0.14% | 131 |
|
|
2021
Q4 | $3.29M | Buy |
52,729
+2,304
| +5% | +$135K | 0.1% | 144 |
|
|
2021
Q3 | $2.98M | Sell |
50,425
-158
| -0.3% | -$10.4K | 0.1% | 142 |
|
|
2021
Q2 | $3.38M | Sell |
50,583
-1,748
| -3% | -$114K | 0.12% | 136 |
|
|
2021
Q1 | $3.3M | Sell |
52,331
-5,448
| -9% | -$339K | 0.14% | 125 |
|
|
2020
Q4 | $3.58M | Buy |
57,779
+477
| +0.8% | +$29.3K | 0.17% | 107 |
|
|
2020
Q3 | $3.46M | Sell |
57,302
-3,232
| -5% | -$195K | 0.19% | 95 |
|
|
2020
Q2 | $3.56M | Buy |
60,534
+9,099
| +18% | +$544K | 0.21% | 95 |
|
|
2020
Q1 | $2.87M | Buy |
51,435
+10,676
| +26% | +$653K | 0.22% | 96 |
|
|
2019
Q4 | $2.62M | Buy |
40,759
+11,628
| +40% | +$666K | 0.16% | 113 |
|
|
2019
Q3 | $1.48M | Buy |
29,131
+10,008
| +52% | +$470K | 0.1% | 127 |
|
|
2019
Q2 | $867K | Sell |
19,123
-42
| -0.2% | -$1.96K | 0.07% | 131 |
|
|
2019
Q1 | $914K | Buy |
19,165
+1,381
| +8% | +$68.8K | 0.08% | 131 |
|
|
2018
Q4 | $924K | Buy |
17,784
+2,636
| +17% | +$142K | 0.1% | 132 |
|
|
2018
Q3 | $940K | Buy |
15,148
+3,745
| +33% | +$222K | 0.09% | 137 |
|
|
2018
Q2 | $631K | Sell |
11,403
-15,356
| -57% | -$829K | 0.06% | 152 |
|
|
2018
Q1 | $1.69M | Sell |
26,759
-1,708
| -6% | -$110K | 0.15% | 124 |
|
|
2017
Q4 | $1.74M | Buy |
28,467
+714
| +3% | +$44.7K | 0.16% | 119 |
|
|
2017
Q3 | $1.77M | Buy |
+27,753
| New | +$1.62M | 0.17% | 114 |
|
|
2017
Q1 | $1.43M | Buy |
26,339
+17,497
| +198% | +$960K | 0.15% | 120 |
|
|
2016
Q4 | $517K | Buy |
8,842
+267
| +3% | +$14.6K | 0.06% | 147 |
|
|
2016
Q3 | $462K | Sell |
8,575
-9,369
| -52% | -$602K | 0.05% | 143 |
|
|
2016
Q2 | $1.32M | Buy |
17,944
+35
| +0.2% | +$2.47K | 0.16% | 102 |
|
|
2016
Q1 | $1.14M | Sell |
17,909
-5,830
| -25% | -$368K | 0.14% | 104 |
|
|
2015
Q4 | $1.63M | Sell |
23,739
-1,433
| -6% | -$94.7K | 0.19% | 88 |
|
|
2015
Q3 | $1.49M | Sell |
25,172
-400
| -2% | -$25.4K | 0.18% | 97 |
|
|
2015
Q2 | $1.7M | Hold |
25,572
| – | – | 0.19% | 96 |
|
|
2015
Q1 | $1.65M | Sell |
25,572
-273
| -1% | -$17.1K | 0.18% | 101 |
|
|
2014
Q4 | $1.53M | Sell |
25,845
-150
| -0.6% | -$8.46K | 0.18% | 104 |
|
|
2014
Q3 | $1.33M | Buy |
25,995
+3
| +0% | +$150 | 0.16% | 123 |
|
|
2014
Q2 | $1.26M | Sell |
25,992
-10,470
| -29% | -$516K | 0.15% | 132 |
|
|
2014
Q1 | $1.89M | Buy |
36,462
+6,945
| +24% | +$370K | 0.23% | 107 |
|
|
2013
Q4 | $1.57M | Sell |
29,517
-150
| -0.5% | -$7.64K | 0.19% | 120 |
|
|
2013
Q3 | $1.37M | Buy |
29,667
+4,095
| +16% | +$180K | 0.18% | 124 |
|
|
2013
Q2 | $1.14M | Buy |
+25,572
| New | +$1.11M | 0.16% | 123 |
|
Other funds holding BMY
VCM
VPM
F.L. Putnam Investment Management's BMY Position: Q1 2026 in Review
F.L. Putnam Investment Management increased its Bristol-Myers Squibb (BMY) stake by 3% in Q1 2026, buying an estimated $353K and bringing the position to 209,651 shares worth $12.7M. The position accounts for 0.19% of the portfolio, ranked #105.
F.L. Putnam Investment Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.5M in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- F.L. Putnam Investment Management held 209,651 shares of Bristol-Myers Squibb worth $12.7M as of Q1 2026.
- F.L. Putnam Investment Management bought 6,050 Bristol-Myers Squibb shares in Q1 2026, an estimated $353K.
- Bristol-Myers Squibb made up 0.19% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #105 holding.
- F.L. Putnam Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- F.L. Putnam Investment Management's Bristol-Myers Squibb position peaked at $13.5M in Q1 2025.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.